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The  findings  presented  in  this  communication  demonstrate  the 
capacity of broth cultures of hemolytic streptococci to liquefy rapidly 
the clotted fibrin of normal human plasma.  The experiments have 
been carried out in such a manner as to emphasize the rapidity with 
which active  cultures transform solid clot into  a  completely liquid 
state, and to bring out other special characteristics of the fibrinolysis 
by  hemolytic streptococci which  differ  in  some  respects  from  the 
orderly  digestion of  solid protein material by  proteolytic  enzymes. 
The  observations contained in  this  report  are  chiefly limited  to  a 
consideration of  the  presence of  fibrinolytic substances in  cultures 
and the conditions of fibrin coagulation which influence the occurrence 
of liquefaction.  Additional lines of investigation, suggested by the 
results, are not yet complete.  Consequently the present  communi- 
cation makes only brief mention of some of the results which will be 
presented in detail in subsequent publications. 
The experimental conditions under which the clot-dissolving prop- 
erty  of  cultures is  most  strikingly demonstrable  consist  in  mixing 
the cultures with plasma or fibrinogen before inducing clot formation. 
By this procedure the organisms and their products are disseminated 
within the body of the clot as it forms, thus affording maximum sur- 
face contact between the active bacterial  agent and the fibrin sub- 
strate.  Under  these  conditions  the  quantity  of  plasma  clot  em- 
ployed in the experiments is liquefied in a  few minutes, whereas the 
same  amount of plasma,  clotted before the addition of cultures, re- 
quires several hours incubation to effect the same degree of dissolution. 
The strains of Streptococcus hemolyticus employed in the tests have 
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been derived from patients  suffering from various  manifestations  of 
acute  streptococcus  infections.  The  sources  of  the  cultures  are 
given in Table I  and the list includes streptococci isolated from cases 
of septicemia, erysipelas, scarlet fever, acute tonsillitis, ceUulitis,  and 
other diseases.  In addition to the human strains, hemolytic strepto- 
cocci  of  animal  origin  have  also  been  used  in  comparable  tests. 
Observations  have  also  been made  with  strains  of other pathogenic 
bacterial  species  for  the  purpose  of  determining  the  presence  or 
absence of a similar fibrinolytic property. 
Whole  plasma  from  human  beings  and  rabbits,  and  fibrinogen 
chemically isolated from the plasma of each species, have served as a 
source of fibrin.  Clot formation was induced by appropriate  coagu- 
lants which are described in the detailed experiments. 
Materials and Methods 
Cultures.--NaC1 meat infusion broth, adjusted to pH 7.6, and containing 0.05 
per cent dextrose, has been the culture medium regularly employed.  The broth 
contains 1 per cent peptone but is not buffered.  The final pH, after growth has oc- 
curred, rarely goes below 7.2.  The tests were performed with fresh cultures which 
had been incubated 18 to 24 hours.  Granular growth was rarely encountered. 
Filtrate.--Ultrafiltration was carried out in the usual manner, aided by suction. 
Berkefdd V, Chamberland,  and Seitz falters were employed.  Sterility of the fil- 
trates was always determined by cultures. 
Anticoagulant.--Potassinm oxalate has been regularly employed in amounts of 
0.02 gin. of oxalate to 10 cc. of blood.  A 2 per cent solution is made in  distilled 
water.  1 ce. of this solution is placed in small bottles which are heated in a dry air 
sterilizer until all water has evaporated.  10 ce. of blood, immediately after with- 
drawal, is mixed with the dried powder.  0.03  to 0.04 gin. of oxalate per 10 co. of 
blood is used to obtain rabbit plasma. 
Preparation of Fibrinogen.--The fraction of plasma proteins precipitated at 25 
per cent saturation with ammonium sulfate has proved to be a suitable fibrinogen 
solution.  To oxalated plasma, a saturated solution of ammonium sulfate is added 
drop by drop until the amount of ammonium sulfate equals one-third the volume 
of plasma.  The mixture is stirred constantly during the addition of ammonium 
sulfate. 
The flocculated protein is collected by centrifugafion, and the supernatant liquid 
is discarded.  The precipitate is washed once with 25 per cent saturated ammo- 
nium sulfate solution, centrifuged, and drained free of wash liquor.  The protein is 
then dissolved in M/100 phosphate buffered physiological salt solution  (pH 7.4). 
The amount of solvent which is added, makes the final protein solution equal the 
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Preparation of Thrombin.l--The method consists of two stages. 
First, precipitation of prothrombin from plasma.  Oxalated plasma is diluted 
with a tenfold volume of cold, distilled water and maintained at ice bath tempera- 
ture while carbon dioxide is passed through the mixture.  After 10 minutes this 
operation is  interrupted  and  the flocculent protein  collected by centrifugation. 
The precipitate is dissolved in a volume of physiological salt solution slightly less 
than the volume of plasma originally employed.  The hydrogen ion concentration 
of this solution is adjusted to pH 7.4 by means of a trace of solid sodium bicarbon- 
ate.  This method separates prothrombin from  the plasma but also precipitates 
some fibrinogen and other plasma proteins. 
Second, conversion of prothrombin into thrombin.  A 2.5 per cent solution of 
calcium chloride is added in a ratio of 1 cc. for each 10 cc. of prothrombin solution. 
After 5 to 10 minutes the solution coagulates to a thick gel.  By careful manipu- 
lation the fibrin is rolled into a  compact mass, and the expressed fluid is filtered 
through paper.  This faintly opalescent solution usually possesses a high coagulat- 
ing activity with either plasma or fibrinogen. 
Fibrinogen and thrombin prepared according to the methods just described are 
sometimes labile and may deteriorate rapidly.  Although some lots of each have 
maintained the original property for several days when kept in the ice box, it is 
best to use the materials on the day of preparation.  In making tests for fibrinoly- 
sis, the physiological activity of both fibrinogen and thrombin was first established. 
Activity was deemed satisfactory when 0.5 cc. of undiluted fibrinogen formed a 
solid clot with 1 drop of thrombin solution. 
Coagulants.  1.  Thrombin.---O.1 cc. of thrombin solution was used to coagulate 
0.2 cc. of plasma or fibrinogen.  This ratio always insured complete clot formation 
in 1 to 3 minutes. 
2.  Calcium Chloride.--0.25 cc. of a 0.25 per cent solution of CaC12 in 0.85  per 
cent salt solution consistently clotted 0.2 cc. of oxalated plasma in 8 to 20 minutes. 
0.3 to 0.35 cc. of 0.25 per cent CaC12 solution was added to rabbit plasma since a 
larger amount of oxalate was mixed with the whole blood.  The solution of calcium 
chloride was sterilized by immersing in boiling water for 30 minutes. 
Oxalated plasma which has stood for 3 days or more is rarely coagulable with 
CaC12.  A distinct delay in clotting is usually noted in 2 day old plasma.  The in- 
ability of calcium to coagulate old oxalated plasma is usually attributed  to the 
rapid deterioration of prothrombin; the addition of thrombin to old plasma results 
in the formation of solid clot. 
In the experiments reported in this article samples of plasma were always tested 
within 24 hours of the time of blood withdrawal. 
Description of Test.--After numerous trials with varying amounts of the different 
constituents,  the following standard procedure was adopted: 0.2  cc.  of oxalated 
1 The authors are indebted to Dr. Harry Eagle for the method by which throm- 
bin solutions were prepared.  The description, presented here, is given with his 
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plasma is diluted with 0.8 cc. of physiological salt solution.  To this 1 to 5 dilution 
of plasma, 0.5 cc. of broth culture or sterile filtrate of test organism is added and 
well mixed.  Coagulant is then added and well mixed; if CaC12 is used, 0.25 cc. of 
0.25 per cent solution is added, if thrombin is employed, 0.1  cc. is added.  The 
tubes are immediately placed in water bath at 37.5°C.  The time at  which  solid 
coagulation occurs is noted.  Solid coagulation is considered  to be effected when 
the tube can be inverted without affecting the solid form of clot which adheres to 
the bottom and sides of the tube; usually no fluid, or only a small drop,  escapes 
from the solid clot on inversion of the tube. 
The tubes are allowed to remain in the water bath under continual observation. 
Complete dissolution  of the dot is recorded as the time at which all evidence of 
fibrin has disappeared, and the contents of the tube are completely fluid.  As dis- 
solution begins, the first softening of the dot may be noted by gently shaking the 
tubes.  This movement causes a wave-like motion to pass vertically down through 
the body of the dot.  The coagulum then releases itself from the sides of the tube 
and usually forms a small mass which, a few minutes later, may be made to disap- 
pear by moderate agitation.  All tests in which  the plasma clot was resistant to 
dissolution  were arbitrarily terminated after 24 hours incubation. 
In the tables presented in this communication "complete dissolution" refers to 
the interval of time between formation of solid  clot and complete liquefaction. 
The time necessary for dot formation is not given special  consideration  in this 
record. 
By recapitulation, a test is as follows: 
0.2 cc. plasma (or fibrinogen)  +  0.8 cc. physiological  salt solution  +  0.5 cc. cul- 
ture (or filtrate) +  0.25 cc. CaC12 (or 0.1 cc. thrombin). 
Unless otherwise specified, all tests were done with standard quantities of the 
various constituents. 
Fibrinolytic  Tests with Human Strains of Hemolytic Streptococci 
Twenty-eight  strains  of  hemolytic  streptococci  of  the  beta type 
(Brown  (1))  have  been  tested  for  the  capacity  to  liquefy  normal 
human plasma clot.  The results are recorded in Table I. 
From the table it can be seen that cultures of all the strains contain 
substances capable of causing fibrinolysis.  Most of the strains effect 
complete dissolution in less than  20 minutes.  With others the speed 
of  clot-liquefaction  varies  but  every strain of hemolytic streptococci 
derived from patients contains the active principle.  Up to the present 
time  no  relationship  has  been  noted  between  the  disease  source  of 
organisms and fibrinolytic potency. 
As noted in the  table some of the  strains were tested immediately 
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TABLE  I 
Strains  of Hemolytic Streptococcus Isolated from  Patients 
Fibrinolytic Activity against Human  Fibrin  Clot 
No.  Source of culture 
Co.  Blood 
Le. 
Ma. 
Bo.  " 
Ot.  Throat 
Hi.  cc 
Bi.  " 
Hu.  " 
Ja.  " 
Th.  " 
Sh.  " 
Mi.  " 
Ur.  " 
Si.  " 
Po. 
Pr.  " 
Zb.  " 
Shy.  " 
Ch.  Ear 
La.  Throat 
Br.  " 
Ro.  Skin 
Pr.  Pleural fluid 
Sm.  Tonsil 
Ta.  " 
Mc.  Throat 
Ba.  Skin pustule 
Lab.  Skin 
Disease 
Septicemia 
~c 
t~ 
Acute tonsillitis 
~g  t, 
g~  gt 
Scarlet fever 
~g  gg 
Igg  lg 
lg  lg 
icg  Iic 
gg  iI1~ 
t[l  lg 
ll  ll 
Otitis media 
Erysipelas 
tc 
Empyema 
Acute nephritis 
Cellulifis 
Length of 
laboratory 
cultivation 
Complete dissolution 
Clot of 
Plasma*  Fibrinogent 
2 yrs.  I0 min.~  2 min.~ 
2  "  10  "  2  " 
2  "  20  " 
1 wk.  10  "  2  " 
2 yrs.  15  " 
4days  40  "  5  " 
4  "  10  "  2  " 
4  "  10  " 
1  yr.  30  " 
6 mos.  40  " 
6  "  10  " 
1  mo.  10  "  2  " 
2 days  50  "  6  " 
2  "  10  "  2  " 
2  "  40  "  4  " 
2  "  15  "  2  " 
2  "  50  "  6  " 
2  "  40  "  6  " 
2  "  20  "  3  " 
2 wks.  10  " 
1 too.  10  " 
6 mos.  25  " 
1 wk.  10  "  2  " 
7 yrs.  10  " 
7  "  15  " 
7  "  10  " 
2 mos.  10  "  2  " 
3  "  20  " 
All tubes incubated in water bath at 37.5°C. 
* Plasma dotted with CaC12 
Fibrinogen clotted  with human  thrombin. 
Time indicated is interval between formation of solid clot and complete lique- 
faction.  Repeated tests have been made with many of the strains.  The average 
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several years.  Strain Co., continually highly active for 12 months, 
has been used in most of the tests.  This strain was originally isolated 
by blood culture from a fatal case of septicemia and has been carried 
in the laboratory for 2  years. 
Although fibrinolytic activity is maximum in freshly transplanted 
cultures which have  been  incubated  18  to  24  hours,  the  property 
may be retained for several days.  Deterioration of the active prin- 
ciple supplied by the organisms, however, is noticeable within 1 to 2 
weeks, even at  ice box temperature.  Consequently, in an attempt 
to  obtain  a  maximum uniform  effect,  broth  cultures  were always 
used  the  day following inoculation.  In spite of  the  fact  that  this 
procedure necessitated the  use of  fresh  subcultures frequently, the 
yield of active material maintained a constant high level. 
In  addition to  tests  performed  with  the  clot  of  whole  plasma, 
fibrinogen has been chemically removed from plasma and used as a 
source of fibrin.  Coagulation, in these instances,  has  been induced 
by the addition of thrombin solutions, also derived from whole blood. 
The fibrin formed by the combination of chemically isolated fibrinogen 
and thrombin solution is called fibrinogen clot in this article, to dis- 
tinguish it from the clot of whole plasma coagulated by calcium which 
is  referred  to  as  plasma  clot.  The  fibrinogen  clot,  consisting  of 
fibrinogen  plus  active  culture  plus  thrombin,  has  been  observed 
for fibrinolysis in exactly the  same manner as  that  employed with 
plasma clot. 
The  results  of  tests  with  15  strains  of  hemolytic streptococcus 
against  fibrinogen clot  are  given in  Table  I  and demonstrate  that 
with this material, fibrinolytic activity proceeds with greater rapidity 
than  it  does  against  the  fibrin  of  whole plasma.  The  culture  of 
Strain  Co.,  for example, which liquefied plasma clot in 10 minutes, 
dissolved  a  relatively  comparable  amount  of  fibrinogen  clot  in  2 
minutes.  The  exact  amount  of  fibrin  in  the  plasma  clot  and  the 
fibrinogen clot was not determined and the comparable experiments 
recorded in the table indicate only the qualitative character of the 
phenomenon rather than  accurate quantitative titrations, which will 
be subsequently published.  That whole plasma contains a property 
which  may  delay  or  even  inhibit  the  fibrinolytic activity of  the 
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Fibrinolytic  Tests  with  Animal  Strains  of Hemolytic  Streptococci 
In addition to the 28 strains of hemolytic streptococci derived from 
patients,  18  strains  from  animal  sources  have  been  similarly tested 
for the capacity to liquefy coagulated plasma and fibrinogen.  These 
strains  are  hemolytic  streptococci  of  the  beta  type  and  equally  as 
active  in  producing  hemolysis  as  the  human  strains.  The  results 
of  tests  with  broth  culture  of  the  18  animal  strains  against  human 
fibrin clot are recorded in Table II. 
TABLE  II 
Animal Strains of Hemolytic Streptococcus 
Fibrinolytic Activity against Human  Fibrin Clot 
No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
Strain 
K 226 
K  158A 
K  158B 
K  158C 
K  158D 
K  158E 
K  158F 
V 10 
K 56 
K 61 
K64 
K  104 
P 454 
j  20 
Br 1 
Br 2 
HI 
R1 
Anlm~source 
Rabbit 
Cow 
Guinea pig 
cg  c¢ 
Complete dissolution 
Clot of 
Plasma*  Fibrinogen  t 
Neg. 24 hrs2; 
"  24  " 
"  24  "  24 
30 rain.  8 rain. 
Neg. 24 hrs.  Neg. 24 
"  24  "  "  24 
"  24  "  "  24 
10 rain.  5 rain. 
Neg. 24 hrs.  Neg. 24 
30 rain.  8 rain. 
Neg. 24 hrs.  Neg. 24 
24  "  "  24 
24  "  "  24  i 
24  "  " 
24  "  I  " 
i 
24  "  " 
24  "  " 
24  "  " 
c¢  c¢  c¢ 
Rabbit  " 
Guinea pig  " 
Horse 
Rabbit  " 
Neg. 24 hrs.:~ 
"  24  " 
hrs. 
c¢ 
c( 
hrs. 
hrs. 
24  " 
24  " 
24  " 
24  " 
24  " 
All tubes incubated in water bath at 37.5°C. 
* Plasma dotted with CaCI~. 
t  Fibrinogen clotted with human thrombin. 
Time indicated is interval between formation of solid clot and complete lique- 
faction.  All experiments terminated after 24 hours incubation. 
Strains 1 to 14 were kindly supplied by Dr. R. C. Lancefield, Hospital of The 
Rockefeller Institute, New York. 
Strains 15 and 16 were kindly supplied by Dr. J. Howard Brown, Department of 
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From the table it can be seen that  15 of these strains are totally 
incapable of inducing  clot liquefaction even though the method of 
experimental procedure was identical with that  used in  testing  the 
human strains. 
Concerning the 3  strains of animal source which liquefied human 
clot,  it is interesting to  record that their cultivation on blood agar 
yielded, with each of the strains,  two distinct types of colony; one 
type was small with a  wide zone of  hemolysis; the other type was 
larger,  tended to  be  mucoid,  and had  a  relatively  smaller zone  of 
hemolysis.  When  these  two  types  of  colonies  were  isolated  and 
grown in broth, the small colony yielded a  culture which  was  inert 
against clot, whereas broth transplant of the larger type of colony was 
highly active in  dissolving coagulated plasma  and fibrinogen.  The 
significance of  this  behavior  of the  culture  is  not  yet understood. 
The 15 strains of animal origin which were inactive produced colonies 
similar to the smaller, strongly hemolytic type. 
The result of the observations with animal strains is interesting in 
that it demonstrates that the capacity to liquefy human clot is absent 
or suppressed in some strains of Streptococcus hemolyticus even though 
the organisms conform in  other cultural  respects to  active strains; 
fibrinolysis does not necessarily parallel hemolysis. 
Fibrinolytic  Tests with Other Human Bacterial Species 
In order to  determine whether or not the fibrinolytic  substances 
are limited to hemolytic streptococci, comparable tests have been per- 
formed with other pathogenic bacteria derived from patients. 
All of the tests have been completely negative.  The list of other 
organisms consists of: 
6 strains of Streptococcus  viridans. 
2 strains of non-hemolytic  streptococci. 
6 strains of streptococci with weak  hemolyzing  property, some  of which have 
been identified  as alpha prime (Brown (1)) variety. 
12 strains of pneumococci  of different types (two  of Type I strain, one of Type 
II, two of Type III, one each of Types VI, VIII, and XIV, three untyped 
Group IV strains, and one R strain of pneumococcus originally derived 
from Type II). 
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2 strains of colon bacillus. 
1 strain each of paratyphoid bacillus  A and B. 
1 strain each of Shiga and Flexner dysentery bacillus. 
2 strains of Freidliinder  bacillus, Types A and B (Julianelle (2)). 
2 strains of hemolytic  influenza  bacillus. 
Altogether 38  strains of organisms other than hemolytic strepto- 
cocci have been examined and in no instance have any of these cul- 
tures affected either clotted plasma or the more susceptible fibrinogen 
clot during the 24 hour test period. 
It will be noted that strains of Staphylococcus aureus and Staphylo- 
coccus albus are not included in the list.  Interesting properties by 
which cultures of staphylococcus affect plasma have been  reported 
by Much (3),  Gratia  (4),  Gross (5),  and others.  They have  found 
that  these  organisms  are  capable  of  coagulating  plasma  sponta- 
neously and some of the articles have reported that liquefaction may 
also occur over a period of several hours.  These properties of staph- 
ylococci are being investigated separately in this laboratory.  Up to 
the  present  time,  fibrinolytic  activity  has  been  found  in  only oc- 
casional strains and, when present, causes dissolution irregularly and 
requires 18 to 24 hours or longer to act. 
With the possible exception, then, of staphylococci, hemolytic strep- 
tococci appear  to  be  unique  among the  species of bacteria  usually 
pathogenic for  human beings in  the  capacity  to transform rapidly, 
solid clotted fibrin into a thin fluid state. 
Fibrinolytic  Tests with Sterile Filtrates of Hemolytic Streptococci 
The observations so far  described have been made by adding to 
plasma, whole broth cultures containing both living organisms and 
the bacterial products present in the medium.  Additional investiga- 
tions have been carried out with sterile, cell-free filtrates, with washed 
organisms, and with cultures grown on solid media. 
The sterile filtrates of 6 strains of hemolytic streptococcus, grown 
in broth, have been tested for the presence of fibrinolytic substances 
by  the use of human plasma clot  and also human fibrinogen clot. 
The results are presented in Table  III.  Filtration has been made 
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contained  in  the  table  were  obtained  with  material  passed  through 
Berkefeld V  candles. 
From  the  table  it may be  seen that,  in  most instances,  0.5  cc.  of 
cell-free filtrate liquefies normal human fibrin clot as rapidly as does 
TABLE  III 
Fibrinolytic  Activity of Sterile Filtrates  of Active Strains of Hemolytic 
Streptococcus against Human Fibrin Clot 
Strains 
Co. 
Le. 
Br. 
Ba. 
Ma. 
Hi. 
Amount of filtrate 
¢¢. 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
Amount of whole 
broth culture 
0.5 
0.5 
0.5 
0.5 
m 
0.5 
0.5 
Complete dissolution 
Clot of 
Plasma*  Fibrinogent 
l0 mm.$ 
lO  " 
10  " 
10  " 
12  " 
10  " 
i5  " 
10  " 
30  " 
20  " 
1 hr.  10 r~n. 
40 rain. 
2 min.~: 
2  " 
2  " 
2  " 
2  " 
2  " 
4  " 
2  " 
6  " 
4  " 
iO  " 
8  " 
All tubes incubated in water bath at 37.5°C. 
* Plasma dotted with CaCI~. 
t  Fibrinogen dotted with human thrombin. 
Time indicated is interval between formation of solid clot and complete lique- 
faction.  Repeated tests have been made with many of the strains.  The average 
rate of dissolution is noted in the table. 
0.5 cc. of whole broth culture; with less active strains, the filtrate acts 
at a slightly slower rate than does whole culture.  The presence of the 
fibrinolytic substances in the filtrate evidences the fact that the active 
principle  is  elaborated  by growing  organisms and  is liberated  freely 
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Titration of Fibrinolytic Activity of Sterile Filtrates 
When whole broth cultures were employed in attempts to  titrate 
quantitatively  the  amount  of  fibrinolytic  substance  present,  the 
presence of living organisms detracted from the accuracy of the results. 
In  such  attempts  the  additional  multiplication  of  bacterial  cells 
which might take place at 37.5°C. was uncontrolled.  By the use of 
sterile filtrates, however, the degree of activity has been more satis- 
factorily estimated. 
Titrations of filtrates have been done both by testing varying  di- 
lutions of filtrate  against a  constant quantity of plasma and fibrino- 
gen,  and  by  testing a  constant quantity of filtrate  against varying 
amounts  of  plasma  and  fibrinogen.  The  results  are  presented 
in Table IV. 
The observations given in the table demonstrate that,  against the 
clot contained in 0.2 cc. plasma, 0.01 cc. of filtrate effects fibrinolysis 
almost as rapidly as does 0.5 cc. of filtrate.  0.005 cc. is slowly active, 
whereas  0.001  cc.  is  ineffectual.  When  progressively  decreasing 
quantities of filtrate were tested against fibrinogen clot, even so small 
an  amount  as  0.0005  cc.  of  filtrate  induced lysis  in  an hour and 5 
minutes.  Smaller quantities of filtrate  have not been tested.  The 
greater susceptibility of fibrinogen-clot is also brought out in the lower 
half of Table V, where the increasing amounts of fibrin substrate are 
exposed to a  constant  quantity  of  active  filtrate.  In  these  experi- 
ments, 0.5 cc. of filtrate required 3 hours and a  half to liquefy 2 cc. 
of plasma clot; whereas 0.5 cc. of filtrate dissolved 10 cc. of fibrinogen 
clot in 30 minutes. 
The titration  of many lots of active filtrate  has resulted in some 
variation  in  quantitative  activity.  The  results  given  in  Table  IV 
were obtained with a  highly active product; in a  few instances even 
more potent material has been obtained. 
When organisms are removed from broth by centrifugation, washed, 
and  resuspended  in  physiological  salt  solution,  their  capacity  to 
dissolve  fibrin  clot  is  considerably  delayed.  In  such  experiments 
liquefaction required 6  to  10 hours.  This was interpreted as being 
chiefly due to the fact that most of the preformed fibrinolytic property 
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the  speed with which additional active material  could be formed by 
the organisms and excreted into the  clot.  A  similar delayed rate of 
dissolution  occurred  when  streptococci  grown  on  blood  agar  were 
washed off and tested for fibrinolytic activity. 
TABLE IV 
Titration of Fibrinolytic A ctivity of Sterile Filtrate against  Human Fibrin Clot 
Amountof  Amountof  ] Time of complete [  Amountof  [  Amountof  ]Timeofcomplet¢ 
filtrate  plasma*  dissolution  filtrate  fibrinogen  t  dissolution 
Decreasing amounts of filtrate against constant quantity of plasma clot and 
fibrino en clot 
t;C. 
0.5 
0. I 
0.05 
0.01 
0.005 
0.001 
0.0005 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
8 min.~ 
10  " 
10  " 
30  " 
6 hrs. 
Neg. 24 hrs. 
CC. 
0.5 
0.1 
0.05 
0.01 
0.005 
0.001 
0.0005 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
0.2 
2 min.$ 
2  t~ 
4  " 
7  " 
10  " 
40  cc 
llhr. 5rain. 
Constant amount of filtrate against increasing quantities of plasma clot and 
fihrinogen clot 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.2 
0.5 
1.0 
2.0 
5.0 
10.0 
7min. 
15  " 
30  " 
3 hrs. 30 rain. 
20 hrs. 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.2 
0.5 
1.0 
2.0 
5.0 
10.0 
2 rain. 
2  " 
3  tc 
4  cc 
5  ~c 
30  " 
All tubes incubated in water bath at 37.5°C. 
* Plasma dotted with  CaCI2. 
t  Fibrinogen clotted with human thrombin. 
Time indicated is interval between formation of solid dot and complete lique- 
faction. 
In each instance the plasma and fibrinogcn was diluted  5 times.  The amount 
of coagulant necessary was calodated on the basis of a standard test (see pages 487 
and  488). 
That  the  active  substances  contained  in  broth  cultures  may  be 
separated  from  the  living  bacterial  cells  has  facilitated  chemical 
studies  on  the  nature  of  the  fibrinolytic  property  elaborated  by 
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cultural  material  and  fibrin  is  comparable  to  enzyme activity,  the 
fibrinolytic  principle  has  special  characteristics  different  from  the 
metabolic proteolytic enzymes of hemolytic streptococci as described 
by  Tongs  (6),  West  and  Stevens  (7),  and  Frobisher  (8).  The  in- 
vestigation has,  therefore, been extended to  include a  study of the 
nature  and  properties  of  the  active  substance.  A  detailed  report 
will follow this preliminary record. 
Resistance to Fibrinolysis by Plasma of Patients Recovered  from Hemolytic 
Streptococcus Infections 
In addition to observations on the occurrence and properties of the 
fibrinolytic substance, the blood of patients and of normal individuals 
has been investigated for the purpose of determining whether or not 
infection with hemolytic streptococci is followed by changes in plasma 
which  are  demonstrable  by  tests  for  susceptibility  to  fibrinolysis. 
Tests  have,  therefore, been  made  on  samples  of plasma  taken  at 
repeated  intervals  before  and  after  recovery  from  infection.  The 
results demonstrate that the plasma clot  from the blood of patients 
recovered from hemolytic streptococcus diseases is often  completely 
resistant to dissolution by active culture.  An analysis of many tests 
on  samples  of blood  taken  during  the  course of disease is  now in 
preparation and will form a separate communication.  At the present 
time it is interesting to record an instance of resistance and also to 
note the fact that  the serum of an individual, whose plasma is  re- 
sistant, may render normal plasma clot insusceptible. 
An example of the resistant effect is given in the following protocol, 
which consists of tests done with the plasma and serum of a patient 
convalescent from erysipelas. 
1. Patient's plasma +  culture +  CaCI~: Negative 24 hours. 
2.  Normal plasma +  culture +  CaC12: Complete dissolution in 10 minutes. 
3.  Normal plasma +  culture 3- 0.1 cc. patient's serum +  CaC12: No dissolu- 
tion in 24 hours. 
4.  Normal plasma 3- culture 3- 0.1 cc. normal serum -t- CaC12: Complete dis- 
solution in 10 minutes. 
Standard quantities of constituents were employed in the experiment. 
Resistance  to  the  fibrinolytic  activity  of  hemolytic  streptococci 
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plasma  of  other  convalescent  patients.  The  absence  of  fibrinolysis 
may  also  be  strikingly  demonstrated  by  the  use  of  normal  animal 
plasma. 
Resistance to Fibrinolysis  by Plasma of Rabbits 
Table  V  contains  the  results  of  fibrinolytic  tests  done  on  rabbit 
plasma  clot  and  rabbit  fibrinogen  clot  with  6  human  strains  and  3 
TABLE  V 
Fibrinolytic  Activity of Human and Animal Strains of Hemolytic Streptococcus 
against Rabbit Fibrin Clot 
No. 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
Strain 
Co. 
Le. 
Br. 
Ba. 
Hu. 
Si. 
K 158A 
K 158B 
K 158C 
K 226 
K 61 
V 10 
Source 
Human 
Activity 
against 
human 
fibrin clot 
Rabbit fibrin clot 
Complete dissolution 
~c 
~c 
Rabbit 
Cow 
4-+4-4- 
+4-+4- 
4-+4-4- 
+4-4-4- 
4-4-+4- 
4-4-4-4- 
N~. 
4-+4- 
Neg. 
4-4-4-4- 
4-4-4-4- 
Clot of 
Plasma*  Fibrinogent 
Neg. 
ct 
gc 
24 hm.~ 
24  " 
24  " 
24  " 
Neg. 24 hrs.~: or 10- 
20 hrs.  Complete 
~g  cc 
Neg. 24 hrs. 
24  "  " 
24  "  " 
24  "  " 
24  "  " 
24  "  " 
24  "  " 
24  "  " 
24  " 
24  " 
24  " 
24  " 
24  " 
24  " 
24  " 
24  " 
24  " 
All tubes incubated in water bath at 37.5°C. 
* Clotted with CaC12. 
t  Clotted with rabbit thrombin. 
~; Experiments arbitrarily terminated at end of 24 hour incubation. 
4- 4- 4- 4- indicates maximum activity (see Table I). 
animal strains of hemolytic streptococci highly active against human 
clot, and with 3 rabbit strains inactive against human fibrin. 
The  complete insusceptibility of rabbit plasma clot to the  fibrino- 
lytic  property  of  the  organisms  contrasts  strikingly  to  the  rapid 
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three young rabbits,  1 month old, has been tested in order to deter- 
mine individual variation.  The results have been uniformly negative. 
The coagulation of separated rabbit fibrinogen, in the presence of 
active culture, by rabbit thrombin results in the formation of a fibrin- 
ogen clot which, in most instances, has been as resistant to dissolu- 
tion  as  the plasma clot.  Exceptions to  this  experience have been 
encountered, however, which are indicated in Table V by the record 
of  dissolution of  fibrinogen  clot  in  10  to  20  hours.  That  rabbit 
fibrinogen clot may occasionally be  slowly liquefied, whereas whole 
rabbit  plasma clot is  not,  indicates that  the factor responsible for 
resistance is greater in whole plasma than in the constituents which 
have been chemically isolated.  The behavior of the rabbit fibrinogen- 
thrombin mixtures, although not identical with the results obtained 
with human material, tends to conform with the results presented in 
Table  I.  An  understanding  of  the  phenomenon  must  await  an 
analysis of the factors which influence the fibrinolytic process. 
Relation of Thrombin to Resistance 
Additional evidence as to the complexity of the mechanism which 
determines the  susceptibility or  resistance  of clot  to  dissolution is 
brought  out  in  experiments  in  which  coagulation  is  induced  by 
different agents.  In the observations so far presented human plasma 
has  been  clotted  by  the addition  of  CaClv  By this method, cal- 
cium promotes the transformation of the prothrombin of the plasma 
into  thrombin, which in  turn  changes  the  fibrinogen  into  fibrin. 
The whole process of coagulation is effected by homologous native 
agents.  Similarly rabbit plasma clotted with calcium behaves in an 
identical manner.  Where  fibrinogen has  been  used for  fibrin  clot, 
coagulation has been effected by homologous thrombin. 
Interesting differences in the susceptibility of clot to the fibrinolytic 
substance of streptococci are brought out by interchanging human 
and animal materials which go to form the fibrin clot.  The results 
are contained in the protocol given below.  In all of the tests listed, 
the coagulation was complete and, from the gross appearance of the 
clot,  the  occurrence of  fibrinolysis could not  be  anticipated.  The 
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solution  or  sterile  uninoculated broth  was  substituted  for  active 
filtrate.  The clot, formed under these conditions, remained intact. 
Time of 
Clot  Clot 
formation  dissolution 
1.  Human plasma  +  filtrate  +  CaCl2  10 min.  10 rain. 
2.  "  "  +  "  +  human thrombin  1  "  6  " 
3.  "  "  +  "  +  rabbit  "  1  "  10  " 
4.  Rabbit plasma  +  filtrate  +  CaCl2  10  "  Neg. 24 hrs. 
5.  "  "  +  "  +  human thrombin  1  "  45 min. 
6.  "  "  +  "  +  rabbit  "  1  "  Neg. 24 hrs. 
7.  Human fibrinogen +  filtrate  +  human thrombin  1  "  2 min. 
8.  "  "  +  "  +  rabbit  "  1  "  4  " 
9.  Rabbit fibrinogen  +  filtrate  +  human thrombin  1  "  4  " 
10.  "  "  +  "  +  rabbit  "  1  "  Neg.  24  hrs.  or 
complete disso- 
lution in 10-20 
hrs. 
From this list it can be seen that when the constituents of the clot 
are  composed  of  human  material,  liquefaction  occurs  promptly. 
Fibrinolysis is rapidly induced by filtrate whether the fibrinogen and 
thrombin are resident in whole plasma or are first chemically separated 
and then recombined.  On the contrary, when the coagulum is made 
up entirely of rabbit substances, the clot remains intact.  An excep- 
tion to this is found in the few instances, already referred to, where 
rabbit fibrinogen plus rabbit thrombin has produced a  clot which is 
finally dissolved after 10 to 20 hours.  The use of human thrombin 
in the coagulation of rabbit  plasma or fibrinogen, however, results 
in the formation of a clot which active filtrate is able to liquefy with 
great rapidity.  Repeated observations have uniformly demonstrated 
that the addition of a  clot constituent from a  susceptible blood to a 
resistant blood results in a  coagulum which active cultural material 
can successfully liquefy. 
At the present time the investigation has not proceeded far enough 
to permit discussion of the mechanism of susceptibility and resistance 
which is manifest under the experimental conditions just described. 
The fibrinogen and thrombin preparations are not purified and un- 
doubtedly contain other blood constituents, the importance of which 
is as yet undetermined.  The observations have,  however,  been  re- WZI,LIAM  S. TILLETT  AND  R.  L.  GARNER  501 
peatedly made and the facts, which have been established, serve as a 
basis for additional investigations. 
SD~M&R¥ 
Broth cultures of hemolytic streptococci derived from patients are 
capable of rapidly liquefying normal human fibrin clot. 
The  active fibrinolytic principle is  also contained in sterile,  cell- 
free filtrates of broth  cultures.  The degree of  activity of filtrates 
parallels the activity of whole broth  cultures sufficiently closely to 
indicate that large amounts of the fibrinolytic substance are freely 
excreted  into  the  surrounding  medium  and  pass  readily  through 
Berkefeld V, Seitz, and Chamberland filters. 
The  occurrence of  fibrinolysis  is  most  strikingly observed  when 
plasma  or fibrinogen is  mixed with active cultural  material before 
clot  formation  is  effected.  Under  the  standard  experimental  con- 
ditions described, complete dissolution of human plasma clot (whole 
oxalated  plasma  +  CaCl~) occurs  in  about  10  minutes;  complete 
dissolution of human fibrinogen clot (chemically isolated fibrinogen + 
thrombin)  takes  place  in  about  2  minutes.  Titration  of  filtrate 
activity is recorded in Table IV. 
Twenty-eight  strains  of  Streptococcus hemolyticus,  isolated  from 
patients  suffering from various  manifestations of  streptococcus in- 
fection,  have  been  tested  for  the  capacity  to  liquefy  fibrin  clot. 
Broth cultures of all of the strains induced fibrinolysis. 
Of  18  strains  of Streptococcus hemolyticus of  animal origin,  only 
three were capable of causing dissolution of clot. 
Completely  negative  results  were  obtained  with  38  strains  of 
other bacterial species.  The list is presented on pages 492 and 493. 
The  plasma  of  many  patients  recovered  from  acute  hemolytic 
streptococcus  infections,  when  clotted  in  the  presence  of  active 
cultures,  is  highly  resistant  to  fibrinolysis.  Furthermore,  serum, 
derived from patients  whose plasma  clot is  resistant,  often  confers 
on  normal plasma  clot  an  antifibrinolytic property.  One  example 
of the resistance possessed by the blood of convalescent patients is 
presented in this report.  A  second paper, now in  preparation, will 
give in detail a  large number of observations on the relation of in- 502  FIBRINOLYSIS BY  HEMOLYTIC STREPTOCOCCI 
fection to the development of resistance to the fibrinolytic activity 
of hemolytic streptococci. 
In contrast  to  the  susceptibility of normal human fibrin  clot  to 
liquefaction  by  active  culture,  normal  rabbit  fibrin  clot  is  totally 
resistant  to  dissolution  when  tested  under  comparable  conditions. 
The  insusceptibility of  rabbit  fibrin  clot  is  manifest  provided  the 
coagulum is composed of rabbit constituents.  When human thrombin 
is used to clot rabbit plasma or fibrinogen in the presence of active 
cultures,  fibrinolysis  is  not  prohibited.  The  r61e of  thrombin  in 
determining the resistance or susceptibility of rabbit fibrin to disso- 
lution offers a suggestive approach to problems relating to the under- 
lying mechanism. 
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